Peter Attia· MD
that tick yeah when you know what mutations exist in the resected tumor it does allow you to create very very sensitive tests for that patient and that's what's being done commercially
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
that tick yeah when you know what mutations exist in the resected tumor it does allow you to create very very sensitive tests for that patient and that's what's being done commercially
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.